Virulence and antibiotic resistance of enterococcus faecalis clinical isolates recovered from three states of mexico. Detection of linezolid resistance

Archives of Medical Research

Volumn 44, Issue 6, 2013, Pages 422-428

  López Salas, Perla ^a   Llaca Díaz, Jorge ^b   Morfin Otero, Rayo ^c   Tinoco, Juan Carlos ^d   Rodriguez Noriega, Eduardo ^c   Salcido Gutierres, Lorena ^d   González, Gloria M ^a   Mendoza Olazarán, Soraya ^c   Garza González, Elvira ^c  

^a Medicina UANL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^d Hospital General de Durango   (Mexico)

Author keywords

Ace; Agg; Biofilm; Enterococcus faecalis; Esp

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CRYSTAL VIOLET; DYE; ERYTHROMYCIN; FOSFOMYCIN; GLUCOSE; LINEZOLID; NITROFURANTOIN; PENICILLIN DERIVATIVE; SAFRANIN; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ACE BACTERIAL GENE; AGG BACTERIAL GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOFILM; CLONAL VARIATION; CONTROLLED STUDY; DILUTION; ENTEROCOCCUS FAECALIS; ESP BACTERIAL GENE; HUMAN; MEXICO; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS;

ACE; AGG; BIOFILM; ENTEROCOCCUS FAECALIS; ESP;

ACETAMIDES; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BIOFILMS; CARRIER PROTEINS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MEMBRANE PROTEINS; MEXICO; OLIGOPEPTIDES; OXAZOLIDINONES; VIRULENCE; VIRULENCE FACTORS;

EID: 84885120455     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.07.003     Document Type: Article

References (33)

1. Elsner H.A., Sobottka I., Mack D., et al. Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur J Clin Microbiol Infect Dis 2000, 19:39-42.
2. Gray J.W., Pedler S.J. Antibiotic-resistant enterococci. J Hosp Infect 1992, 21:1-14.
3. Morrison A.J., Wenzel R.P. Nosocomial urinary tract infections due to Enterococcus. Ten years' experience at a university hospital. Arch Intern Med 1986, 146:1549-1551.
4. Sava I.G., Heikens E., Huebner J. Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect 2010, 16:533-540.
5. Dworniczek E., Piwowarczyk J., Bania J., et al. Enterococcus in wound infections: virulence and antimicrobial resistance. Acta Microbiol Immunol Hung 2012, 59:263-269.
6. Tsikrikonis G., Maniatis A.N., Labrou M., et al. Differences in biofilm formation and virulence factors between clinical and fecal enterococcal isolates of human and animal origin. Microbial Pathogenesis 2012, 52:336-343.
7. Klibi N., Ben Slama K., Saenz Y., et al. Detection of virulence factors in high-level gentamicin-resistant Enterococcus faecalis and Enterococcus faecium isolates from a Tunisian hospital. Can J Microbiol 2007, 53:372-379.
8. Johansson D., Rasmussen M. Virulence factors in isolates of Enterococcus faecalis from infective endocarditis and from the normal flora. Microb Pathog 2013, 55:28-31.
9. Chow J.W., Thal L.A., Perri M.B., et al. Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1993, 37:2474-2477.
10. Kreft B., Marre R., Schramm U., et al. Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect Immun 1992, 60:25-30.
11. Shankar V., Baghdayan A.S., Huycke M.M., et al. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun 1999, 67:193-200.
12. Nallapareddy S.R., Singh K.V., Duh R.W., et al. Diversity of ace, a gene encoding a microbial surface component recognizing adhesive matrix molecules, from different strains of Enterococcus faecalis and evidence for production of ace during human infections. Infect Immun 2000, 68:5210-5217.
13. Harbarth S., Cosgrove S., Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002, 46:1619-1628.
14. Kristich C.J., Li Y.H., Cvitkovitch D.G., et al. Esp-independent biofilm formation by Enterococcus faecalis. J Bacteriol 2004, 186:154-163.
15. Mohamed J.A., Huang W., Nallapareddy S.R., et al. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect Immun 2004, 72:3658-3663.
16. Dupre I., Zanetti S., Schito A.M., et al. Incidence of virulence determinants in clinical Enterococcus faecium and Enterococcus faecalis isolates collected in Sardinia (Italy). J Med Microbiol 2003, 52:491-498.
17. Clinical Laboratory Standards Institute M-A. Methods for Dilution: Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically:2012.
18. Miranda A.G., Singh K.V., Murray B.E. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol 1991, 29:2752-2757.
19. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
20. Donelli G., Guaglianone E. Emerging role of Enterococcus spp in catheter-related infections: biofilm formation and novel mechanisms of antibiotic resistance. J Vasc Access 2004, 5:3-9.
21. Toledo-Arana A., Valle J., Solano C., et al. The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol 2001, 67:4538-4545.
22. Upadhyaya G.P., Lingadevaru U.B., Lingegowda R.K. Comparative study among clinical and commensal isolates of Enterococcus faecalis for presence of esp gene and biofilm production. J Infect Dev Ctries 2011, 5:365-369.
23. Hallgren A., Claesson C., Saeedi B., et al. Molecular detection of aggregation substance, enterococcal surface protein, and cytolysin genes and invitro adhesion to urinary catheters of Enterococcus faecalis and E. faecium of clinical origin. Int J Med Microbiol 2009, 299:323-332.
24. Willems R.J., Homan W., Top J., et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 2001, 357:853-855.
25. Duggan J.M., Sedgley C.M. Biofilm formation of oral and endodontic Enterococcus faecalis. J Endodont 2007, 33:815-818.
26. Tendolkar P.M., Baghdayan A.S., Gilmore M.S., et al. Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun 2004, 72:6032-6039.
27. Ruiz-Garbajosa P., Canton R., Pintado V., et al. Genetic and phenotypic differences among Enterococcus faecalis clones from intestinal colonisation and invasive disease. Clin Microbiol Infect 2006, 12:1193-1198.
28. Panesso D., Reyes J., Rincon S., et al. Molecular epidemiology of vancomycin-resistant Enterococcus faecium: a prospective, multicenter study in South American hospitals. J Clin Microbiol 2010, 48:1562-1569.
29. Ntokou E., Stathopoulos C., Kristo I., et al. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis andEnterococcus faecium. J Antimicrob Chemother 2012, 67:1819-1823.
30. Gomez-Gil R., Romero-Gomez M.P., Garcia-Arias A., et al. Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital. Diagn Microbiol Infect Dis 2009, 65:175-179.
31. Lopez Marti M.G., Jhaveri R. Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease. Pediatr Infect Dis J 2009, 28:663-664.
32. Werner G., Coque T.M., Hammerum A.M., et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008, 13.
33. Zilberberg M.D., Shorr A.F., Kollef M.H. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005. Emerg Infect Dis 2008, 14:1756-1758.